The psychological status in patients with nasopharyngeal carcinoma during radiotherapy
- PMID: 34110454
- DOI: 10.1007/s00405-021-06892-5
The psychological status in patients with nasopharyngeal carcinoma during radiotherapy
Abstract
Purpose: The psychological status of nasopharyngeal carcinoma (NPC) patients cannot be ignored. Few studies have studied the dynamic changes and influencing factors of psychological status in NPC patients during radiotherapy. The purpose of this study was to investigate the changing trends and risk factors of anxiety and depression in NPC patients during radiotherapy.
Methods: Demographic and clinical data of 232 newly treated NPC patients were collected. Before radiotherapy, the fourth week, and the end of radiotherapy were observational timepoints. Anxiety and depression states were evaluated by the hospital anxiety and depression scale.
Results: Scores of anxiety before radiotherapy, in the fourth week and at the end of radiotherapy were 6.32 ± 3.19, 7.87 ± 3.49, and 9.08 ± 3.69, respectively (P < 0.001). Incidence rates of anxiety were 34.0%, 55.1%, and 64.0% (P < 0.001). Depression scores were 5.31 ± 3.19, 7.07 ± 3.63, and 8.32 ± 3.89 (P < 0.001). Incidence rates of depression were 25.0%, 43.9%, and 56.0% (P < 0.001). Gender, age, education level, smoking, and treatment-related toxicity scores (P < 0.05) were independent risk factors for anxiety in patients with NPC during radiotherapy, while age, education level, and treatment-related toxicity scores (P < 0.05) were independent risk factors for depression in these patients.
Conclusion: The incidence and degree of anxiety and depression in NPC patients increased during radiotherapy. Age, education level, and treatment-related side effects influenced anxiety and depression. More psychological nursing should be given to the NPC patients who are more likely to suffer from psychological distress.
Keywords: Anxiety; Depression; Head and neck; Nasopharyngeal carcinoma; Radiotherapy.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
References
-
- Chen YP, Chan ATC, Le QT et al (2019) Nasopharyngeal carcinoma. Lancet 394(10192):64–80. https://doi.org/10.1016/s0140-6736(19)30956-0 - DOI - PubMed
-
- Sun Y, Li WF, Chen NY et al (2016) Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomised controlled trial. Lancet Oncology 17(11):1509–1520. https://doi.org/10.1016/S1470-2045(16)30410-7 - DOI - PubMed
-
- Hong JS, Tian J, Han QF et al (2015) Quality of life of nasopharyngeal cancer survivors in China. Curr Oncol 22(3):e142–e147. https://doi.org/10.3747/co.22.2323 - DOI - PubMed - PMC
-
- Guo C, Huang Y, Yu J, et al (2017) The impacts of single nucleotide polymorphisms in genes of cell cycle and NF-kB pathways on the efficacy and acute toxicities of radiotherapy in patients with nasopharyngeal carcinoma. Oncotarget 8(15): 25334–25344. https://doi.org/10.18632/oncotarget.15835
-
- Wang C, Wang F, Min X et al (2019) Toxicities of chemoradiotherapy and radiotherapy in nasopharyngeal carcinoma: an updated meta-analysis. J Int Med Res 47(7):2832–2847. https://doi.org/10.1177/0300060519858031 - DOI - PubMed - PMC
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources